Premium
A MULTICENTER, OPEN LABEL, UNCONTROLLED, PHASE II TRIAL EVALUATING SAFETY AND EFFICACY OF VENETOCLAX, ATEZOLIZUMAB ANDOBINUTUZUMAB IN RICHTER TRANSFORMATION FROM CLL
Author(s) -
Montillo M.,
Rossi D.,
Zucca E.,
Frustaci A.M.,
Pileri S.,
Cavalli F.,
Tedeschi A.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.4_2632
Subject(s) - obinutuzumab , venetoclax , atezolizumab , medicine , rituximab , oncology , chronic lymphocytic leukemia , lymphoma , immunology , cancer , leukemia , immunotherapy , pembrolizumab
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom